The company led by Joaquin Duato launches a rebranding as it focuses on higher-risk prescription drugs and medical devices after shedding its consumer business.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
Joaquin Duato early last year assumed the role of CEO after spearheading the growth of J&J’s pharmaceutical unit.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New faces, new struggles, new celebrations in 'Welcome to Wrexham' season 2'Welcome to Wrexham' season 2 preview: new faces, new struggles and lots of reasons to rejoice.
Read more »
New faces, new struggles, new celebrations in 'Welcome to Wrexham' season 2'Welcome to Wrexham' season 2 preview: new faces, new struggles and lots of reasons to rejoice.
Read more »
Baseball: New Rules, New Stars, New SongsBaseball seemed to reinvent itself in 2023. There were new rules, new stars, and new songs, thanks to a new album from the Baseball Project.
Read more »
Johnson & Johnson is getting rid of its script logo after more than 130 yearsJohnson & Johnson is signing off on a new logo, more than 130 years after creating the old one.
Read more »
Johnson & Johnson is getting rid of its script logo after more than 130 yearsJohnson & Johnson is signing off on a new logo, more than 130 years after creating the old one.
Read more »
Man, 15-year-old boy wanted in shooting of 18-year-old woman in northeast HoustonA man and teen are wanted in a shooting that left an 18-year-old woman injured on Sunday in northeast Houston, according to the Houston Police Department.
Read more »